Naveris, Inc., a leader in molecular diagnostics for viral cancers, announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.
The...
Drugmaker Eli Lilly & Co announced that the FDA has issued a complete response letter, meaning it has not granted accelerated approval for amyloid-clearing...
RevBio, Inc., announced that it has received approval from the Italian Ministry of Health and the Ethics Committee of the University “G.D'Annunzio” of Chieti-Pescara...
Replica Analytics Ltd, an Aetion® company, has announced a series of new training courses, titled Practical De-identification Methods for Health Data, intended to help...
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting a new scientific publication describing the safety...
